| __timestamp | Catalyst Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 38783000000 |
| Thursday, January 1, 2015 | 8597010 | 42585000000 |
| Friday, January 1, 2016 | 7910260 | 45702000000 |
| Sunday, January 1, 2017 | 7304399 | 46372000000 |
| Monday, January 1, 2018 | 15875961 | 46910000000 |
| Tuesday, January 1, 2019 | 36881187 | 48890000000 |
| Wednesday, January 1, 2020 | 44233754 | 50129000000 |
| Friday, January 1, 2021 | 49628000 | 54559000000 |
| Saturday, January 1, 2022 | 58183000 | 62081000000 |
| Sunday, January 1, 2023 | 133710000 | 105931000000 |
| Monday, January 1, 2024 | 77201000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Dr. Reddy's Laboratories Limited and Catalyst Pharmaceuticals, Inc. over the past decade.
From 2014 to 2023, Dr. Reddy's Laboratories consistently reported SG&A expenses that were significantly higher than those of Catalyst Pharmaceuticals. In 2023, Dr. Reddy's expenses peaked at approximately 105.9 billion, marking a 173% increase from 2014. In contrast, Catalyst Pharmaceuticals saw a dramatic rise in 2023, with expenses reaching 133.7 million, a staggering 2,889% increase from 2014.
While Dr. Reddy's Laboratories shows a steady growth in SG&A expenses, Catalyst Pharmaceuticals' recent surge suggests a strategic shift or expansion. Understanding these trends can provide investors and stakeholders with valuable insights into each company's operational strategies and market positioning.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Catalyst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Catalyst Pharmaceuticals, Inc.
Insmed Incorporated or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: BioMarin Pharmaceutical Inc. vs Catalyst Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Veracyte, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared